Women and Heart Disease

Information about coronary heart disease (CHD) and cardiovascular disease in women is rapidly escalating, likely as a component of the concept of sex-specific medicine during the past decade. Medical reports and public information about women and heart disease now proliferate and the under-representation of women in clinical trials is reversing. New sex-specific clinical data are being published. In this second edition of Women & Heart Disease, Nanette Kass Wenger and Peter Collins present contributions from 81 international leaders in women's cardiovascular health and disease, offering a concise and well-referenced resource in 43 chapters to the practicing physician that incorporates all the latest information. It is this emerging new information about cardiovascular disease in women, and its application in daily clinical practice, which is likely to improve clinical cardiovascular outcomes for women. Book jacket.